Bacteriostatic and bactericidal activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium in human macrophages

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 6, 1996, Pages 1482-1485

  Mor, Natan ^a   Simon, Benjamin ^a   Heifets, Leonid ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; BENZOXAZINORIFAMYCIN; ISONIAZID; PYRAZINAMIDE; RIFALAZIL; RIFAMPICIN; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; HUMAN; HUMAN CELL; MACROPHAGE FUNCTION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

ANTIBIOTICS, ANTITUBERCULAR; CELLS, CULTURED; HUMANS; MACROPHAGES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; RIFAMYCINS; TIME FACTORS;

EID: 0029950710     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.6.1482     Document Type: Article

References (16)

1. Dhillon, J., and D. A. Mitchison. 1992 Activity in vitro of Rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium micron and M. tuberculosis and their penetration into mouse peritoneal macrophages. Am. Rev Respir. Dis. 145:212-214.
2. Dickinson, J. M., and D. A. Mitchison. 1987. In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosis Tubercle 68:183-193.
3. Dickinson, J. M., and D. A. Mitchison. 1987. In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis. Tubercle 68:113-119.
4. Dickinson, J. M., and D. A. Mitchison. 1981. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis. Am. Rev. Respir. Dis. 145:212-214.
5. Heifets, L. B., M. D. Iseman, P. J. Lindholm-Levy, and W. Kanes. 1985. Determination of ansamycin MICs for Mycobacterium avium. Antimicrob. Agents Chemother. 28:570-575.
6. Heifets, L. B., P. J. Lindholm-Levy, and M. A. Flory. 1990. Bactericidal activity in vitro of various rifamycins against M. avium and M. tuberculosis. Am. Rev. Respir Dis. 141:626-630.
7. Hirata, T., H. Saito, H. Tomioka, K. Sato, J. Jidoi, K. Hosoe, and T. Hidaka. 1995. In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 39: 2295-2303.
8. Klemens, S. P., and M. Cynamon. 1991. In vivo activities of newer rifamycin analogs against Mycobacterium avium infection. Antimicrob. Agents Chemother. 35:2026-2030.
9. Luna-Herrera, J., M. Venkata Reddy, and P. R. J. Gangadharam. 1995. In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli. Antimicrob. Agents Chemother. 39:440-444
10. Mor, N., B. Simon, and L. Heifets. 1995. Methods for determining concentrations of antimicrobial agents in human monocytes. J. Chemother. 7:207-209.
11. Mor, N., J. Vanderkolk, and L. Heifets. 1994. Inhibitory and bactericidal activities of levofloxacin against M. tuberculosis in vitro and in human macrophages. Antimicrob. Agents Chemother. 38:1161-1164.
12. Mor, N., J. Vanderkolk, N. Mezo, and L. Heifets. 1994. Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium Antimicrob Agents Chemother. 38:2738-2742.
13. Nibbering, P. H., T. P. L. Zomerdisk, A. J. Corsel-Van Tilberg, and R. Van Furth. 1990. Mean cell volume of human blood leukocytes and resident and activated murine macrophages. J. Immunol. Methods 129:143-145.
14. Saito, H., H. Tomioka, K. Sato, S. Kawahara, T. Hidaka, and S. Dekio. 1995. Therapeutic effect of KRM-1648 with various antimicrobials against M avium complex infection in mice. Tubercle Lung Dis. 76:51-58.
15. Tomioka, H., H. Saito, K. Fujii, K. Sato, and T. Hidaka. 1993. In vitro antimicrobial activity of benzoxazinorifamycin KRM-1648 against Mycobacterum avium complex, determined by the radiometric method. Antimicrob Agents Chemother. 37:67-70.
16. Tomioka, H., H. Saito, K. Sato, T. Yamane, K. Yamashita, K. Hosoe, K. Fujii, and T. Hidaka. 1992 Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin. KRM-1648, against Mycobacterium avium complex infection induced in mice. Antimicrob Agents Chemother. 36:387-393.